KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Exchange Rate Effect for 13 consecutive years, with -$104000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 91.01% to -$104000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $458000.0, a 127.39% increase, with the full-year FY2025 number at $458000.0, up 127.39% from a year prior.
  • Exchange Rate Effect was -$104000.0 for Q4 2025 at Xenon Pharmaceuticals, down from -$6000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $814000.0 in Q4 2022 to a low of -$2.7 million in Q3 2022.
  • A 5-year average of -$195700.0 and a median of -$35000.0 in 2025 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: soared 1079.71% in 2022, then plummeted 722.03% in 2024.
  • Xenon Pharmaceuticals' Exchange Rate Effect stood at $69000.0 in 2021, then skyrocketed by 1079.71% to $814000.0 in 2022, then crashed by 69.78% to $246000.0 in 2023, then crashed by 570.33% to -$1.2 million in 2024, then soared by 91.01% to -$104000.0 in 2025.
  • Per Business Quant, the three most recent readings for XENE's Exchange Rate Effect are -$104000.0 (Q4 2025), -$6000.0 (Q3 2025), and $632000.0 (Q2 2025).